John Cochran, MD
Chestatee Pathology Associates, PC
John Cochran, MD, is the Chief Executive Officer of Chestatee Pathology Associates, PC (Atlanta, GA). He is the Medical Director of two Atlanta-area hospital laboratories. Dr. Cochran has consulted on the following companies: Genzyme, ePocrates, Cerner, NextGen, AllScripts, GE Healthcare, Immucor, Beckman Coulter, Siemens (Bayer/Dade Behring), GenProbe, Cryolife, Quest Diagnostics (Ameripath), LabCorp, Clarient, Biorad, Abbott, Regeneration Technologies, Ortho, Olympus, BD (TriPath), Hologic (Cytyc), Qiagen/Digene, Inverness Medical (Biosite), Roche (Ventana), Affymetrix, Danaher (Dako), Lab Vision, Stryker, Sakura Finetek, Leica, Cardinal, Thermo Fisher, Sunquest/Misys, Sysmex, UpToDate, Ovid, MDConsult (Elsevier), and McKesson (Per Se). He has experience in anatomic pathology, laboratory medicine, lab automation systems, EMRs, group purchasing, blood banking, information systems, lab regulations, medical billing, cancer drugs, and medical education resources. (This is me - Update Profile)
| 2000 - present | Founder and Senior Pathologist Chestatee Pathology Associates, PC |
|---|
GLG Study Groups with John Cochran, MD(?)
| Study Group Name | Members |
|---|---|
| Pathologists (US) | 829 |
| Users of Provue system for blood screening | 14 |
| Users of Triage BNP Test (US) | 29 |
| Pricing Experts on Clinical Lab Testing in the U.S. | 58 |
GLG NewsSM Analyses by John Cochran, MD(?)
View all GLG News in Healthcare
GLG InstituteSM Seminars with John Cochran, MD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with John Cochran, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

